Quantcast

Latest Chikungunya Stories

2011-05-06 00:25:40

Researchers probing genetics of chikungunya virus identify tiny changes separating epidemic African strain and tamer Asian variety What causes a virus to suddenly begin infecting large numbers of people? Scientists have long known that the process they call "viral emergence" involves a wide variety of factors. Some are changes in the environment, either generated by natural causes or human activity. Others are internal, arising from accidental changes "” mutations "”in the virus'...

2011-05-05 11:52:00

MENLO PARK, Calif., May 5, 2011 /PRNewswire/ -- In parts of the world where dengue fever is common, other viral infections are often misdiagnosed. Such misdiagnosis is a waste not only of time and money. It can be especially problematic for sufferers of another mosquito-borne viral infection called chikungunya--its high fever, joint pain that can last for years, and intense headache symptoms mimic the clinical profile of dengue. Recovery from the acute phase of the infection can take from...

2011-02-16 14:55:07

 The Singapore Immunology Network (SIgN), an institute of the Agency of Science, Technology and Research (A*STAR), and VIVALIS (NYSE Euronext: VLS), a French biopharmaceutical company, announced today the discovery of two new fully human monoclonal antibodies which could battle Chikungunya, a disease that currently has no available vaccine or specific treatment. The international team of scientists, coordinated by Dr Lucile Warter of SIgN, has published their groundbreaking discovery in...

2010-07-15 05:00:00

ROCKVILLE, Md., July 15 /PRNewswire/ -- MacroGenics, Inc, a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced that the National Institutes of Health (NIH) has awarded the company three new grants representing total funding of $9.8 million. These grants will help MacroGenics further advance its Dual-Affinity Re-Targeting (DART), or bispecific antibody scaffold platform, as well as its...

fc12b629dcaf68dcce33e78331de1369
2010-03-05 08:03:14

Mosquito-borne virus has infected millions of people in Asia, Africa and Europe Imagine a mosquito-borne virus that has already infected millions of people in recent outbreaks in South and Southeast Asia, the islands of the Indian Ocean, Africa and northern Italy. Although seldom fatal, it causes highly painful arthritis-like symptoms that can linger for months or even years. It's capable of adapting to spread through a mosquito species common in much of North America. And no vaccine or...

2010-02-01 12:23:42

A study published online on February 1 in the Journal of Experimental Medicine (www.jem.org) shows that antiviral proteins called type I interferons (IFNs) are needed to fend off infection with an exotic mosquito-borne virus called Chikungunya virus. This pathogen, which causes high fevers and severe joint pain, triggered a recent epidemic in Southeast Asia, infecting more than 30% of the population in some areas. A team led by Marc Lecuit and Matthew Albert at the Pasteur Institute in Paris...

2010-01-28 19:47:41

An experimental vaccine developed using non-infectious virus-like particles (VLP) has protected macaques and mice against chikungunya virus, a mosquito-borne pathogen that has infected millions of people in Africa and Asia and causes debilitating pain, researchers at the National Institutes of Health have found. Scientists at the National Institute of Allergy and Infectious Diseases (NIAID) developed the vaccine because there is no vaccine or treatment for chikungunya virus infection. Details...

20703fe7892a2e73741592c6e9b07eff1
2009-12-25 15:20:00

Earlier this year, researchers showed that they could cut the lives of disease-carrying mosquitoes in half by infecting them with a bacterium they took from fruit flies. Now, a new report in the December 24th issue of Cell, a Cell Press publication, suggests that their strategy might do one better: The Wolbachia bacteria also makes the mosquitoes more resistant to infection by viruses that are a growing threat to humans, including those responsible for dengue fever and Chikungunya. Once...

2009-11-06 07:35:00

SPRING VALLEY, Calif., Nov. 6 /PRNewswire/ -- Calbiotech, Inc. announced today that it has been awarded a Small Business Innovative Research (SBIR) Phase I contract by the U.S. Army Medical Research and Material command. Under terms of the agreement, Calbiotech will develop analyte specific reagents (ASRs) for the diagnosis of Dengue virus. Dengue virus is a mosquito-born flavivirus that represents a major threat to military forces deployed to tropical areas of the world. Due to its...

fd5a268511c77ab4e53b765d529ec5561
2009-09-21 06:35:00

Most people will recall the West Nile virus scare that incited fear throughout North America just 10 years ago; however new mosquito-borne diseases in the U.S. and Europe are posing a farther greater health risk, an expert in the U.S. said on Friday. The Chikungunya virus first popped up in Africa in 2005, but has now greatly spread, leaving a trail of outbreaks and enumerable deaths in India and the French island of Reunion. Cases have even been reported in Italy and France, where the virus...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.